Skip to main content
. Author manuscript; available in PMC: 2015 Jun 8.
Published in final edited form as: Cancer Res. 2004 Sep 15;64(18):6797–6804. doi: 10.1158/0008-5472.CAN-04-1068

Table 4.

Relative colonic gene expression in n-3 versus n-6 or n-9 fed AOM-injected rats at the promotion stage

Accession no. P Relative expression
Gene name
n-3/n-6 n-3/n-9
Apoptosis
   X07648 0.00836 0.585 0.731 Amyloidogenic glycoprotein (rAG)
Cell cycle/Cell growth
   NM 019242 0.00270 1.369 1.374 IFN-related developmental regulator 1 (Ifrd1)
Channels/Transporters
   NM 017251 0.00119 0.704 0.677 Gap junction membrane channel protein β 1 (Gjb1)
   NM 012654 0.00465 1.356 1.336 Solute carrier family 9, member3 (Slc9a3)
   D50664 0.00498 1.665 1.411 Oligopeptide transporter
   AF029310 0.00867 1.424 1.513 Vanilloid receptor subtype 1
Cytoskeleton/Extracellular matrix
   NM 012983 0.00035 0.509 0.497 Unconventional myosin (Myr4)
   D14048 0.00843 1.596 1.612 SP120
Kinases and related
   D78588 0.00319 0.692 0.734 Diacylglycerol kinase
   AF007789 0.00678 1.405 1.487 Urokinase receptor
Metabolism/Redox
   AF186469 0.00240 1.461 1.400 TM6P1
Receptors
   AF090347 0.00022 0.717 0.711 Putative G-protein coupled receptor GPCR91
Trafficking and transport
   AF144756 0.00566 2.507 2.077 Adipocyte lipid-binding protein (ALBP)
Transcription
   L09647 0.00239 0.649 0.682 Hepatocyte nuclear factor 3a (HNF-3 β)
   AF003944 0.00313 0.678 0.714 Ovalbumin upstream promoter β nuclear receptor rCOUPb
   J04147 0.00400 0.490 0.577 1,25-dihydroxyvitamin D-3 receptor
   AF037199 0.00465 1.513 1.882 Zinc finger transcription factor REST protein

NOTE. Rats received injections of AOM and were terminated 10 weeks later. See footnote to Table 1 for additional details.